Earnings ·
LivaNova reports Q3 revenue of $393.1M, raises full-year adjusted EPS guidance to $4.40-$4.50
LIVNLivaNova PLC
LivaNova PLC reported third-quarter 2026 net revenue of $393.1 million, a 9.9% increase from the prior year period. Adjusted diluted earnings per share reached $1.23, up from $1.11 in Q3 2025. The company raised its full-year 2026 adjusted diluted EPS guidance midpoint by $0.10 to $4.40-$4.50 and increased the constant-currency revenue growth range to 9%-10%. LivaNova is a global medical technology company focused on neurological and cardiac conditions.